Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | RXRA | P19793 | 1/20 | 0.32 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.32 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14715394 | 0.71 | SMO (0.41) | GAAALDH1A1MAPTMAPK1CYP1A2 | |
| SCHEMBL21770664 | 0.71 | RXRA (0.42) | ALDH1A1KMT2AKDM4ELMNASMN1; SMN2 | |
| SCHEMBL2412730 | 0.68 | RXRA (0.42) | ALDH1A1KMT2AKDM4ELMNAMAPT | |
| SCHEMBL14974219 | 0.68 | ALDH1A1 (0.59) | GAAALDH1A1KMT2AKDM4ELMNA | |
| Hydrochloric Acid SCHEMBL14974213 | 0.67 | ALDH1A1 (0.58) | GAAALDH1A1KMT2AKDM4ELMNA | |
| SCHEMBL14973631 | 0.67 | L3MBTL1 (0.53) | GAAALDH1A1KDM4ELMNASMN1; SMN2 | |
| SCHEMBL14973718 | 0.67 | GAA (0.42) | GAAALDH1A1KDM4ELMNASMN1; SMN2 | |
| SCHEMBL31517348 | 0.67 | MAPT (0.52) | GAAALDH1A1KMT2AKDM4ELMNA | |
| SCHEMBL14974307 | 0.66 | GAA (0.43) | GAAALDH1A1KDM4ELMNASMN1; SMN2 | |
| SCHEMBL14715160 | 0.65 | SMN1; SMN2 (0.39) | GAAALDH1A1KDM4ELMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130136794-A1 | HETEROARYL (ALKYL) DITHIOCARBAMATE COMPOUNDS, PREPARATION METHODS AND USES THEREOF | PEKING UNIVERSITY (CN) | 2013-05-30 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130136794-A1 | HETEROARYL (ALKYL) DITHIOCARBAMATE COMPOUNDS, PREPARATION METHODS AND USES THEREOF | LTK, ERBB2, ABL1 | GAA 1564/4885ALDH1A1 2942/4885KMT2A 1408/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.